Finally, a definitive diagnosis of CJD typically requires a combination of clinical findings, neuroimaging, electroencephalography (EEG), and cerebrospinal fluid biomarkers, including 14-3-3 protein, tau protein, and the RT-QuIC assay [4, 11, 12]. Here, MAPT is linked to Creutzfeldt Jacob disease.